Cardurion pharmaceuticals llc
WebAug 2, 2024 · Cardurion is a biotechnology company focused on the development of novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases. The company has facilities in Cambridge, Massachusetts and Shonan, Japan. For more information, visit http://www.cardurion.com. Takeda’s Forward-Looking Statements WebOct 27, 2024 · October 27, 2024 07:30 AM Eastern Daylight Time. BOSTON-- ( BUSINESS WIRE )--Cardurion Pharmaceuticals, Inc. (“Cardurion” or “the Company”), a clinical-stage …
Cardurion pharmaceuticals llc
Did you know?
WebConsulting LLC Sarah Boyce CEO Avidity Biosciences Doug Drysdale CEO Cybin Nerissa Kreher, MD Biotech Executive Bruce Goldsmith Consultant Aureum Bio Safia Rizvi ... Cardurion Pharmaceuticals Ben Wang Cofounder and COO Chimera Bioengineering Jessica Sagers Head of Engagement RA Capital Clifford Stocks CEO OncoResponse WebSep 7, 2024 · September 7, 2024, 9:05 AM · 1 min read Imara Inc (NASDAQ: IMRA) has agreed to divest tovinontrine (IMR-687) and all other assets related to its PDE9 program to Cardurion Pharmaceuticals Inc.
WebJan 27, 2024 · Filed: September 24, 2024. Date of Patent: September 28, 2024. Assignee: Cardurion Pharmaceuticals, LLC. Inventors: Nobuyuki Matsunaga, Yasufumi … WebJan 5, 2024 · WSI PBG, LLC Jun 2024 - Apr 2024 11 months - Developed and closed new pharmaceutical manufacturer contracts contributing to annual sales goals ... Thrilled to join the excellent team at Cardurion ...
WebTakeda-backed cardiovascular disease specialist Cardurion Pharma has a new investor and $300 million in cash to play with after Bain Capital joined the supporting cast. WebSep 20, 2024 · Cardurion Pharmaceuticals is a biotechnology company with both clinical and preclinical programs focused on the development of novel, next-generation therapeutics for the treatment of heart failure and other cardiovascular diseases.
WebCardurion Pharmaceuticals. Research & Development · Massachusetts, United States · <25 Employees . Cardurion Pharmaceuticals is a biotechnology company focused on …
WebCardurion Pharmaceuticals is a biotechnology company focused on the discovery and development of next-generation therapeutics for the treatment of heart failure and other … rsbi intubationWebMar 18, 2024 · Erika Volckova is a CMC Vice President, Manufacturing at Cardurion Pharmaceuticals based in Boston, Massachusetts. Read More Contact Erika Volckova's Phone Number and Email Last Update 10/26/2024 12:48 AM Email e***@cardurion.com Engage via Email Contact Number (***) ***-**** Engage via Phone Mobile Number (***) … rsbi chartWebJul 19, 2024 · BOSTON, July 19, 2024--Cardurion Pharmaceuticals, Inc. ("Cardurion" or "the Company"), a clinical-stage biotechnology company developing next-generation therapeutics for the treatment of ... rsbi thresholdWebNov 10, 2024 · Message : * Required fields. Cardurion Pharmaceuticals, LLC entered into an asset purchase agreement to acquire Tovinontrine (IMR-687) and All of the Assets … rsbi of 95WebCardurion Pharmaceuticals has raised a total of $343.2M in funding over 5 rounds. Their latest funding was raised on Dec 30, 2024 from a Debt Financing round. Cardurion Pharmaceuticals is funded by 3 investors. Polaris Partners and Bain Capital are the most recent investors. Funding Rounds Number of Funding Rounds 5 Total Funding Amount … rsbih facebookWebAbout us. Cardurion is a clinical-stage cardiovascular biotechnology company developing new therapeutics for the treatment of heart failure and cardiovascular diseases. … rsbigdog oh.rr.comWebNov 20, 2024 · About Cardurion Pharmaceuticals. Cardurion Pharmaceuticals is a biotechnology company with both clinical and preclinical programs focused on the development of novel, next-generation therapeutics ... rsbite vendor show